{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:17:47Z","timestamp":1790162267969,"version":"4.1.0"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Alzheimer disease (AD) is characterized by amyloid-\u03b2 plaques (A), tau tangles (T), and neurodegeneration (N), collectively defining the ATN framework. While imaging biomarkers are well-established, the prognostic value of plasma biomarkers in predicting cognitive decline remains underexplored. This study compares plasma and imaging A\/T\/N biomarkers in predicting cognitive decline and evaluate the impact of combining biomarkers across modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>We conducted a longitudinal study using K-ROAD cohort participants who underwent at least 2 cognitive assessments. All participants had plasma biomarker testing (A\u03b2 ratio, p-tau181, p-tau231, p-tau217, NfL), and a subset with imaging biomarker assessments (A\u03b2 PET, tau PET, structural MRI) formed an imaging subcohort. Multiple linear regression models identified the most predictive markers within each modality and evaluated the effect of combining A\/T\/N biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 1,614 plasma cohort and 130 imaging subcohort participants, tau markers demonstrated the strongest predictive value. p-tau217\n                      <jats:sub>MSD<\/jats:sub>\n                      outperforming other plasma biomarkers, and the neo-temporal ROI showing the highest predictive power among imaging biomarkers. In plasma-based model, adding neurodegeneration markers to combination of amyloid and tau biomarkers improved the performance. In imaging-based models, same strategy decreased the performance, suggesting that combinations of amyloid and tau PET captures the most relevant prognostic information.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Imaging biomarkers, particularly tau PET, show superior prognostic accuracy compared with plasma biomarkers, whereas plasma biomarkers offer advantages in combination models through neurodegeneration markers. These findings underscore the complementary roles of plasma and imaging biomarkers and emphasize the need for tailored strategies for prognostic modeling in AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006088","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T14:00:46Z","timestamp":1757080846000},"page":"1120-1129","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Value of A\/T\/N Biomarkers"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-768X","authenticated-orcid":false,"given":"Sohyun","family":"Yim","sequence":"first","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3200-3977","authenticated-orcid":false,"given":"Yuna","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"},{"name":"Department of Health Sciences and Technology, SAIHST, Sungkyunkwan UniversitySeoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-6818","authenticated-orcid":false,"given":"Heekyung","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-1026","authenticated-orcid":false,"given":"Daeun","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Jongno-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4341-6906","authenticated-orcid":false,"given":"Heejin","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg; Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK"},{"name":"UK Dementia Research Institute at UCL; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, UK"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg; Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Paris Brain Institute (ICM), Department of Neurology, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Sorbonne University, Paris, France"},{"name":"Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-9456","authenticated-orcid":false,"given":"Fernando","family":"Gonzalez-Ortiz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg; Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-8804","authenticated-orcid":false,"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"},{"name":"Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia, South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-1954","authenticated-orcid":false,"given":"Michael W","family":"Weiner","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA"},{"name":"Department of Medicine, University of California, San Francisco, CA"},{"name":"Department of Psychiatry, University of California, San Francisco, CA"},{"name":"Department of Neurology, University of California, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Day","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-6214","authenticated-orcid":false,"given":"Eun Hye","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0098-7592","authenticated-orcid":false,"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-9441","authenticated-orcid":false,"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"},{"name":"Department of Health Sciences and Technology, SAIHST, Sungkyunkwan UniversitySeoul, Republic of Korea"},{"name":"Alzheimer\u2019s Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea"},{"name":"Alzheimer\u2019s Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-0302","authenticated-orcid":false,"given":"Sung Hoon","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4564-9714","authenticated-orcid":false,"given":"Ko Woon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jeonbuk National University Medical School and Hospital, Jeonju, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6564-3774","authenticated-orcid":false,"given":"Yeo Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3770-2359","authenticated-orcid":false,"given":"Jaeho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3731-6132","authenticated-orcid":false,"given":"Min Young","family":"Chun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea"},{"name":"Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-9508","authenticated-orcid":false,"given":"Na Yeon","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pusan National University Yangsan Hospital, Research Institute for Convergence of Biomedical Science and Technology, Yangsan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyun","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4376-3107","authenticated-orcid":false,"given":"Jun Pyo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2436-4947","authenticated-orcid":false,"given":"Jihwan","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea"},{"name":"Department of Health Sciences and Technology, SAIHST, Sungkyunkwan UniversitySeoul, Republic of Korea"},{"name":"Alzheimer\u2019s Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea"},{"name":"Alzheimer\u2019s Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the K-ROAD study groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"R1-20251114","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"R2-20251114","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R3-20251114","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"R4-20251114","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"R5-20251114","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"R6-20251114","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.2967\/jnumed.121.263195","article-title":"The role of amyloid PET in imaging neurodegenerative disorders: a review","volume":"63","author":"Chapleau","year":"2022","journal-title":"J Nucl Med"},{"key":"R7-20251114","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"R8-20251114","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"R9-20251114","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of Tau deposition in the aging human brain","volume":"89","author":"Scholl","year":"2016","journal-title":"Neuron"},{"key":"R10-20251114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"R11-20251114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/alzrt47","article-title":"Role of structural MRI in Alzheimer\u2019s disease","volume":"2","author":"Vemuri","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"R12-20251114","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement"},{"key":"R13-20251114","doi-asserted-by":"crossref","first-page":"e8763","DOI":"10.15252\/emmm.201708763","article-title":"Amyloid blood biomarker detects Alzheimer\u2019s disease","volume":"10","author":"Nabers","year":"2018","journal-title":"EMBO Mol Med"},{"key":"R14-20251114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"R15-20251114","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"key":"R16-20251114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"key":"R17-20251114","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","article-title":"Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications","volume":"18","author":"Gonzalez-Ortiz","year":"2023","journal-title":"Mol Neurodegener"},{"key":"R18-20251114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","article-title":"Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease","volume":"10","author":"Lewczuk","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"R19-20251114","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J Neurol"},{"key":"R20-20251114","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"R21-20251114","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molmed.2022.05.008","article-title":"Staging of Alzheimer\u2019s disease: past, present, and future perspectives","volume":"28","author":"Therriault","year":"2022","journal-title":"Trends Mol Med"},{"key":"R22-20251114","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma beta-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"R23-20251114","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat Med"},{"key":"R24-20251114","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer\u2019s disease","volume":"28","author":"Mila-Aloma","year":"2022","journal-title":"Nat Med"},{"key":"R25-20251114","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/awad042","article-title":"Predicting amyloid PET and tau PET stages with plasma biomarkers","volume":"146","author":"Jack","year":"2023","journal-title":"Brain"},{"key":"R26-20251114","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol"},{"key":"R27-20251114","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"R28-20251114","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"R29-20251114","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/brain\/awaa088","article-title":"Microglial activation and tau burden predict cognitive decline in Alzheimer\u2019s disease","volume":"143","author":"Malpetti","year":"2020","journal-title":"Brain"},{"key":"R30-20251114","doi-asserted-by":"crossref","first-page":"338ra366","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease","volume":"8","author":"Brier","year":"2016","journal-title":"Sci Transl Med"},{"key":"R31-20251114","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann Neurol"},{"key":"R32-20251114","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nicl.2013.03.014","article-title":"Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer\u2019s disease","volume":"2","author":"Vandenberghe","year":"2013","journal-title":"Neuroimage Clin"},{"key":"R33-20251114","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.24711","article-title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum","volume":"80","author":"Cho","year":"2016","journal-title":"Ann Neurol"},{"key":"R34-20251114","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"key":"R35-20251114","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/WNL.0000000000002892","article-title":"Tau PET in Alzheimer disease and mild cognitive impairment","volume":"87","author":"Cho","year":"2016","journal-title":"Neurology"},{"key":"R36-20251114","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/alz.12466","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities","volume":"18","author":"Syrjanen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"R37-20251114","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement"},{"key":"R38-20251114","doi-asserted-by":"crossref","first-page":"e14368","DOI":"10.1002\/alz.14368","article-title":"Plasma Alzheimer\u2019s disease biomarker variability: amyloid-independent and amyloid-dependent factors","volume":"21","author":"Lee","year":"2024","journal-title":"Alzheimers Dement"},{"key":"R39-20251114","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1212\/WNL.0000000000207419","article-title":"Association of chronic kidney disease with plasma NfL and other biomarkers of neurodegeneration: the H70 birth cohort study in Gothenburg","volume":"101","author":"Dittrich","year":"2023","journal-title":"Neurology"},{"key":"R40-20251114","doi-asserted-by":"crossref","first-page":"1150510","DOI":"10.3389\/fnagi.2023.1150510","article-title":"Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer\u2019s disease","volume":"15","author":"Zhang","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"R41-20251114","doi-asserted-by":"crossref","first-page":"e12321","DOI":"10.1002\/dad2.12321","article-title":"Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology","volume":"14","author":"Berry","year":"2022","journal-title":"Alzheimers Dement (Amst"},{"key":"R42-20251114","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2967\/jnumed.122.264279","article-title":"A head-to-head comparison between plasma pTau181 and Tau PET along the Alzheimer\u2019s disease continuum","volume":"64","author":"Coomans","year":"2023","journal-title":"J Nucl Med"},{"key":"R43-20251114","doi-asserted-by":"crossref","first-page":"e14398","DOI":"10.15252\/emmm.202114398","article-title":"Tau PET correlates with different Alzheimer\u2019s disease-related features compared to CSF and plasma p-tau biomarkers","volume":"13","author":"Ossenkoppele","year":"2021","journal-title":"EMBO Mol Med"},{"key":"R44-20251114","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/alz.12875","article-title":"Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients","volume":"19","author":"Smith","year":"2023","journal-title":"Alzheimers Dement"},{"key":"R45-20251114","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13195-023-01302-w","article-title":"Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment","volume":"15","author":"Mundada","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"R46-20251114","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","article-title":"Combining plasma Abeta and p-tau217 improves detection of brain amyloid in non-demented elderly","volume":"16","author":"Niimi","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"R47-20251114","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41467-021-23746-0","article-title":"Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations","volume":"12","author":"Cullen","year":"2021","journal-title":"Nat Commun"},{"key":"R48-20251114","doi-asserted-by":"crossref","first-page":"e12490","DOI":"10.1002\/trc2.12490","article-title":"Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer\u2019s disease patients","volume":"10","author":"Matthews","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"key":"R49-20251114","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41380-021-01263-2","article-title":"Alzheimer\u2019s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline","volume":"26","author":"Bucci","year":"2021","journal-title":"Mol Psychiatry"},{"key":"R50-20251114","doi-asserted-by":"crossref","first-page":"212","DOI":"10.12779\/dnd.2024.23.4.212","article-title":"Korea-registries to overcome dementia and accelerate dementia research (K-ROAD): a cohort for dementia research and ethnic-specific insights","volume":"23","author":"Jang","year":"2024","journal-title":"Dement Neurocogn Disord"},{"key":"R51-20251114","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/brain\/aww148","article-title":"Relative impact of amyloid-beta, lacunes, and downstream imaging markers on cognitive trajectories","volume":"139","author":"Kim","year":"2016","journal-title":"Brain"},{"key":"R52-20251114","first-page":"7556","article-title":"Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories","volume":"20","author":"Jang","year":"2024"},{"key":"R53-20251114","first-page":"129","article-title":"Predicting conversion of brain \u03b2-amyloid positivity in amyloid-negative individuals","volume":"14","author":"Park","year":"2022"},{"key":"R54-20251114","doi-asserted-by":"crossref","first-page":"135","DOI":"10.12779\/dnd.2025.24.2.135","article-title":"Establishing regional A\u03b2 cutoffs and exploring subgroup prevalence across cognitive stages using BeauBrain Amylo","volume":"24","author":"Park","year":"2025","journal-title":"Dement Neurocogn Disord"},{"key":"R55-20251114","first-page":"735","article-title":"Association of factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020"},{"key":"R56-20251114","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1109\/TMI.2002.806283","article-title":"Automatic \u201cpipeline\u201d analysis of 3-D MRI data for clinical trials: application to multiple sclerosis","volume":"21","author":"Zijdenbos","year":"2002","journal-title":"IEEE Trans Med Imaging"},{"key":"R57-20251114","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","article-title":"Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space","volume":"18","author":"Collins","year":"1994","journal-title":"J Comput Assist Tomogr"},{"key":"R58-20251114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans Med Imaging"},{"key":"R59-20251114","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuroimage.2004.07.045","article-title":"Cortical thickness analysis examined through power analysis and a population simulation","volume":"24","author":"Lerch","year":"2005","journal-title":"Neuroimage"},{"key":"R60-20251114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuroimage.2005.11.042","article-title":"Gender difference analysis of cortical thickness in healthy young adults with surface-based methods","volume":"31","author":"Im","year":"2006","journal-title":"Neuroimage"},{"key":"R61-20251114","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.neuroimage.2006.10.041","article-title":"An unbiased iterative group registration template for cortical surface analysis","volume":"34","author":"Lyttelton","year":"2007","journal-title":"Neuroimage"},{"key":"R62-20251114","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1053-8119(02)00017-4","article-title":"Deformation-based surface morphometry applied to gray matter deformation","volume":"18","author":"Chung","year":"2003","journal-title":"Neuroimage"},{"key":"R63-20251114","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.mri.2013.04.008","article-title":"Fully-automated approach to hippocampus segmentation using a graph-cuts algorithm combined with atlas-based segmentation and morphological opening","volume":"31","author":"Kwak","year":"2013","journal-title":"Magn Reson Imaging"},{"key":"R64-20251114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.12779\/dnd.2024.23.3.117","article-title":"A Comparison of item characteristics and test information between the K-MMSE~2:SV and K-MMSE","volume":"23","author":"Kim","year":"2024","journal-title":"Dement Neurocogn Disord"},{"key":"R65-20251114","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2353\/ajpath.2010.100346","article-title":"Abeta accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model","volume":"177","author":"Hurtado","year":"2010","journal-title":"Am J Pathol"},{"key":"R66-20251114","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"R67-20251114","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"Gotz","year":"2001","journal-title":"Science"},{"key":"R68-20251114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"R69-20251114","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","article-title":"Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging","volume":"78","author":"Ossenkoppele","year":"2021","journal-title":"JAMA Neurol"},{"key":"R70-20251114","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"R71-20251114","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"R72-20251114","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl Neurodegener"},{"key":"R73-20251114","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-160726","article-title":"Mitochondrial Aspects of synaptic dysfunction in Alzheimer\u2019s disease","volume":"57","author":"Cai","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"R74-20251114","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1007\/s00415-019-09400-2","article-title":"In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer\u2019s disease","volume":"266","author":"Terada","year":"2019","journal-title":"J Neurol"},{"key":"R75-20251114","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/msj.20163","article-title":"Relationship between tau pathology and neuroinflammation in Alzheimer\u2019s disease","volume":"77","author":"Metcalfe","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"R76-20251114","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"R77-20251114","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13195-021-00953-x","article-title":"Serum neurofilament light chain level as a predictor of cognitive stage transition","volume":"14","author":"Lee","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"R78-20251114","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","volume":"28","author":"Ossenkoppele","year":"2022","journal-title":"Nat Med"},{"key":"R79-20251114","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"R80-20251114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"key":"R81-20251114","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","article-title":"Overview of tau PET molecular imaging","volume":"35","author":"Cassinelli Petersen","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"R82-20251114","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/WCO.0000000000000904","article-title":"Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer\u2019s disease","volume":"34","author":"Leuzy","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"R83-20251114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13195-023-01210-z","article-title":"Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer\u2019s disease","volume":"15","author":"Xie","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"R84-20251114","doi-asserted-by":"crossref","first-page":"11307","DOI":"10.1038\/s41598-024-61655-6","article-title":"Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in subjective cognitive decline and mild cognitive impairment","volume":"14","author":"Giacomucci","year":"2024","journal-title":"Sci Rep"},{"key":"R85-20251114","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.2967\/jnumed.121.263196","article-title":"Tau PET imaging in neurodegenerative disorders","volume":"63","author":"Groot","year":"2022","journal-title":"J Nucl Med"},{"key":"R86-20251114","first-page":"e413","article-title":"RMJCnm. Brain PET in the diagnosis of Alzheimer\u2019s disease","volume":"39","author":"Marcus","year":"2014"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:00:50Z","timestamp":1763125250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006088"}},"subtitle":["Comparing Plasma and Imaging Modalities in Alzheimer Disease"],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006088","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"2025-04-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}